Combination of an FXR agonist and an ACC inhibitor increases anti-fibrotic efficacy in rodent models of NASH

Authors

Keywords

Journal

Volume 68, Issue -, Pages S395-S396

Publisher

Elsevier BV

Online

2018-04-23

DOI

10.1016/s0168-8278(18)31026-2

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now